CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 82 filers reported holding CYTOSORBENTS CORP in Q3 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $94,760 | +20.5% | 11,670 | +28.8% | 0.00% | 0.0% |
| Q1 2021 | $78,658 | -5.9% | 9,062 | -13.6% | 0.00% | 0.0% |
| Q4 2020 | $83,565 | -0.1% | 10,485 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $83,618 | -19.4% | 10,485 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $103,802 | +85.3% | 10,485 | +23.7% | 0.00% | +100.0% |
| Q2 2019 | $56,033 | -12.7% | 8,477 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $64,171 | -23.9% | 8,477 | -18.8% | 0.00% | -50.0% |
| Q4 2018 | $84,371 | -37.4% | 10,442 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $134,702 | -99.9% | 10,442 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $119,039,000 | – | 10,442 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skylands Capital, LLC | 1,772,000 | $13,379,000 | 1.58% |
| Sargent Investment Group, LLC | 856,315 | $6,465,000 | 1.53% |
| Avenir Corp | 1,366,549 | $10,317,000 | 0.82% |
| CM Management, LLC | 150,000 | $1,133,000 | 0.82% |
| Winning Points Advisors, LLC | 136,900 | $1,035,000 | 0.78% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 185,000 | $1,397,000 | 0.46% |
| SECTORAL ASSET MANAGEMENT INC | 244,660 | $1,847,000 | 0.15% |
| Redmile Group, LLC | 1,304,369 | $9,848,000 | 0.15% |
| Granahan Investment Management | 1,003,546 | $7,577,000 | 0.14% |
| ACT CAPITAL MANAGEMENT, LLC | 35,000 | $265,000 | 0.14% |